Although the country is in the midst of the darkest period of the coronavirus pandemic, with emergency authorization of a COVID-19 vaccine imminent and distribution of initial doses expected to start this month, the beginning of the end is starting to come into focus.Today a panel of experts that advises the Food and Drug Administration (FDA) on drug approval is meeting to review data on the vaccine candidates from Pfizer-BioNTech.
Emergency use authorization (EUA) for the vaccine could come shortly thereafter. The advisory committee will review data on the Moderna vaccine on Dec 17.Officials with Operation Warp Speed, the US government's effort to develop and distribute COVID-19 vaccines and therapeutics, say distribution of the initial